We have compared the effects of lidocaine (L) to those of several derivatives in an attempt to determine the sites of action and active forms of the molecules. We studied cardiac Purkinje fibers with intracellular microelectrodes, and drugs were administered by supervision or by iontophoretic intracellular injection. We compared to L the effects of QX-314 and QX-572, two quaternary derivatives, and also compound 6603, a tertiary analogue with a pK a of 9.81. When administered by supervision in concentrations of 10~5 and 10" 4 M, all four agents exerted qualitatively similar effects on the transmembrane action potential. The rate of onset of action of the quaternary derivatives was considerably slower than that of L and their actions were not reversed by supervision for 1 hour with drug-free solution. Comparison of effects of L and QX-314 after intracellular injection showed that attenuation of V mu , and thus of the fast inward current, results from interaction of the charged form acting from the inner surface of the sarcolemma. After intracellular injection, QX-314 diffused readily along the long axis of fiber bundles, and it was thus possible to expose the inner surface of a large number of contiguous cells to drug. Comparison of results of extracellular and intracellular application suggests that effects on the voltage during phase 2 result from the charged form acting from the inner surface, but effects on total action potential duration result only from drug acting from the outer surface of the sarcolemma. Unlike L, the three derivatives did not decrease the slope of normal phase 4 depolarization. The results may help relate antiarrhythmic action to specific effects on transmembrane potentials.
Sites of Action and Active Forms of Lidocaine and Some Derivatives on Cardiac
Purkinje Fibers JERRY I. GLIKLICH AND BRIAN F. HOFFMAN SUMMARY We have compared the effects of lidocaine (L) to those of several derivatives in an attempt to determine the sites of action and active forms of the molecules. We studied cardiac Purkinje fibers with intracellular microelectrodes, and drugs were administered by supervision or by iontophoretic intracellular injection. We compared to L the effects of QX-314 and QX-572, two quaternary derivatives, and also compound 6603, a tertiary analogue with a pK a of 9.81. When administered by supervision in concentrations of 10~5 and 10" 4 M, all four agents exerted qualitatively similar effects on the transmembrane action potential. The rate of onset of action of the quaternary derivatives was considerably slower than that of L and their actions were not reversed by supervision for 1 hour with drug-free solution. Comparison of effects of L and QX-314 after intracellular injection showed that attenuation of V mu , and thus of the fast inward current, results from interaction of the charged form acting from the inner surface of the sarcolemma. After intracellular injection, QX-314 diffused readily along the long axis of fiber bundles, and it was thus possible to expose the inner surface of a large number of contiguous cells to drug. Comparison of results of extracellular and intracellular application suggests that effects on the voltage during phase 2 result from the charged form acting from the inner surface, but effects on total action potential duration result only from drug acting from the outer surface of the sarcolemma. Unlike L, the three derivatives did not decrease the slope of normal phase 4 depolarization. The results may help relate antiarrhythmic action to specific effects on transmembrane potentials.
FOR NERVE it has been shown that lidocaine and similar local anesthetics modify excitability and the action potential because the uncharged form of the molecule penetrates the membrane and the charged form, acting from within the axon, attenuates the time-and voltage-dependent changes in sodium and potassium conductance initiated by depolarization. 1 ' 2 Lidocaine also is an important antiarrhythmic drug and there have been many studies of its effects on the electrical activity of fibers from normal and diseased hearts. 3 " 6 In the case of cardiac Purkinje fibers, typically lidocaine decreases the duration of the transmembrane action potential by abbreviating the plateau (phase 2) and decreases the slope of depolarization during phase 4. This latter effect is thought to be due to an increase in potassium conductance. 7 Lidocaine also decreases the maximum rate of depolarization during the upstroke of the transmembrane action potential 3 ' 5 ' 6 and slows reactivation of the fast sodium channel on repolarization. 8 ' 9 The intensity of the effect on the fast channel is strongly dependent on extracel-lular potassium concentration ([K + ] o ). 10 High concentrations of lidocaine also cause a loss of resting potential. 3 ' 5 - 6 Although it is reasonable to assume that the effect of lidocaine on the fast inward channel (g Na ) of cardiac fibers results from an action similar to that demonstrated for nerve, there are no data describing the sites at which each of the several effects of lidocaine on Purkinje fibers are exerted or the form of the molecule responsible for them. We have attempted to obtain some information relating to these questions. We emphasized the comparison of two agents: lidocaine, (pK a = 7.88), and a quarternary ethyl lidocaine derivative, QX-314. In addition we examined the effects of QX-572, a quaternary lidocaine that has shown some promise as a clinical antiarrhythmic drug, 11 ' 12 and compound 6603, a tertiary lidocaine analogue with a pK a of 9.81. The structural formulas of each are shown in Figure 1 .
Our results show that, as expected, the effects of lidocaine and its derivatives on gNa are exerted by the charged form acting from the inner surface of the membrane. In contrast, effects on action potential duration (phases 2 and 3) appear to be due primarily to drug molecules interacting with the outer surface of the sarcolemma. Also, by altering the molecule it is possible to separate effects on phase 0 and phases 2 and 3 from effects on phase 4 of the transmembrane potential. These findings should be of some help in studies which attempt to determine the electrophysiological mechanism for an arrhythmia by observing its response to antiarrhythmic agents which exert specific effects on the electrical activity of cardiac cells.
Methods
Mongrel dogs weighing 15-30 kg were anesthetized with sodium pentobarbital, 30 mg/kg, iv. The heart was rapidly removed through a right lateral thoracotomy and placed in cool oxygenated Tyrode's solution containing (in mM/liter): NaCl, 137; NaHCO 3 , 12; dextrose, 5.5; NaH 2 PO 4 , 1.8; MgCl 2 , 0.5; CaCl 2 , 2.7; and KC1, 2.7. For some experiments we also used Tyrode's solution with a K + concentration of 4.0 mM. Purkinje fiber bundles were excised from the right and left ventricles and mounted in a Lucite chamber. Temperature in this chamber was maintained at 36-37°C by superfusion at a flow rate of 12 ml/min with Tyrode's solution warmed to 40°C and gassed with 95%0 2 -5%C0 2 . The Purkinje fiber bundles were stimulated at a constant cycle length (500-1500 msec in different experiments) through Teflon-coated bipolar silver wire electrodes placed on the surface of the fiber bundle. These stimuli were 1-2 msec in duration and their strength was 1.25-2X threshold.
Transmembrane potentials were recorded through glass capillary microelectrodes filled with 3 M KC1 and selected for resistances of 10-30 MS2.
The microelectrodes were connected through Ag-AgCl junctions to amplifiers with high input resistance and input capacity neutralization. The perfusion chamber was electrically grounded through a similar junction. Transmembrane potentials were displayed on one channel of a Tektronix RM 565 oscilloscope; an operational amplifier was used to obtain the first time derivative of phase 0 of the transmembrane action potential (V max ) and this was displayed on the other channel of the RM 565 at a high sweep velocity. A sawtooth calibration pulse of 100 mV and 0.5 msec was injected between the tissue chamber and ground and permitted calibration of the record of V max . The differentiation was linear between 100 and 800 V/sec. The methods used to record and measure action potential amplitude, membrane activation voltage (MAV, the transmembrane potential at the onset of phase 0), maximum diastolic potential (MDP), and action potential duration have been described previously. 3 To compare the effects of lidocaine and its derivatives when they were added to the superfusing Tyrode's solution, we used the following methods. To make a quantitative comparison of membrane resting and action potentials, the preparation was driven at a constant rate and records were obtained from the same cells during a 60-minute control period, during exposure for periods of 60 minutes to the test agent in concentrations first of 1 X 10~5 M and then 1 X 10~4 M and finally during superfusion with control Tyrode's solution (washout) for 60 minutes. Each preparation was exposed to only one test agent. These studies provided data permitting evaluation of drug-induced changes in resting potential, action potential amplitude and duration, and V m ax-This method did not, however, permit quantitative comparison of the effects of the test agents on the slope of phase 4 depolarization because this value varied considerably among the preparations and at different sites in a single preparation. Therefore, in other experiments, to obtain records from a relatively large number of fibers exhibiting phase 4 depolarization of similar magnitude, we recorded the transmembrane potential from the same 8 to 15 marked sites in the Purkinje fiber bundle under control conditions, during exposure to the test agent, and again during superfusion with control Tyrode's solution. Because effects of lidocaine are readily reversed during superfusion with control solution, for some of these experiments we first measured the effect of lidocaine on phase 4, then superfused the fiber with control solution for 60 minutes, and then exposed it to one of the three test agents. In other experiments we studied the effect of lidocaine after the fiber had been exposed to one of the other three agents.
To compare the effects of a test agent added to the Tyrode's solution to the effects observed when the same agent was directly injected into the fiber, we used standard iontophoretic techniques. For these experiments we used two intracellular micro- VOL. 43, No. 4, OCTOBER 1978 electrodes; one contained 3 M KC1 and the other lidocaine or QX-314 or QX-572. The electrode containing the test agent was used alternately to inject drug into the impaled cell and to record the transmembrane potential; the other electrode recorded the changes in transmembrane potential at a known distance from the point of injection. Microelectrodes for intracellular iontophoresis were prepared from standard microelectrodes by replacing the 3 M KC1 in the shank with 0.5 M lidocaine (pH = 3.5) or QX-314 and equilibrating the pipette tip overnight in the same solution. In a limited number of experiments, we also studied the effects of intracellular injection of QX-572. Iontophoresis was accomplished with positive pulses of predetermined amplitude, duration, and frequency, delivered by a constant current generator; current was measured between the tissue bath and ground and monitored on a third trace on the oscilloscope. Switching between the current source and the amplifier was accomplished with high-speed relays. Usually, to reduce the likelihood that the microelectrode might be displaced or blocked during current injection, we used a pulse of 500 msec during phase 4 of each of a series of transmembrane action potentials.
For some experiments, as indicated, the injection and recording electrodes were maintained in the same fibers throughout the control and test periods. For other experiments, to obtain additional information about the spatial distribution of drug effects caused by intracellular injection, we used the following method. After the transmembrane potential had been recorded at 10-15 sites along the fiber, the test agent was injected by the above-described method into one or more cells, and periodically the original recording sites were reimpaled and studied. Such a set of measurements allowed the construction of an electrophysiological "map" illustrating action potential changes as a function of time and position relative to the injection sites.
Terms denoting the pacemaker conductance and current, gk,2 and ik,2, the delayed outward current, i,,i, and the secondary inward current, i S j (also labeled the calcium current, ic a 2+ ) have been defined by Noble. 13 
Results

Drug Application by Supervision
We first compared the effects of each of the four agents when they were added to the Tyrode's solution and thus they gained initial access to the outer surface of the fiber membrane. Records showing typical effects of each agent after exposure to concentrations of 10" 5 and 10~4 M for 60 minutes are shown in Figure 2 . The magnitude of effect on selected parameters is presented in Table 1 . Lidocaine caused the expected changes in the transmembrane potentials. At 10~5 M there was no significant change in MDP, action potential amplitude, or V max , but there was a clear effect on repolarization. This was brought about by more rapid repolarization during phase 2 and an earlier onset of phase 3. At 10~4 M lidocaine caused a decrease in The effects of QX-314, QX-572, 6603 and lidocaine on the transmembrane potential. For each drug and experimental condition listed, the following measurements are tabulated as percent of control values (±SD): membrane activation voltage (MAV), action potential amplitude (AP), action potential duration measured at 50% repolarization (APDw), and at 90% repolarization (APDM), and the maximum slope of phase 0 (Vmax). The number of impalements studied under the given condition is shown in parentheses. In each instance, impalements were maintained throughout the experiment and measurements were made after exposure for 1 hour to the solution indicated. The second control observation was made after perfusion with drug-free Tyrode's solution for 60 minutes. The first significant change from control for each drug is shown: * P < 0.05; f P < 0.01; $ P < 0.001. Stimulus cycle length = 1000 msec, [ action potential amplitude from a control value of 144 to 136 mV, a decrease in MAV from -90 to -83 mV and a fall in V max from 820 to 740 V/sec. There was some decrease in MDP. At this time APD50 (the time to 50% repolarization) had decreased from a control value of 320 msec to 165 msec and APD90 from 410 to 280 msec. The maximum effect of each concentration of lidocaine developed within 10 minutes and, during washout with control solution, restoration of control values was virtually complete within 30 minutes. For Figure 2 , after washout, action potential amplitude was 140 mV, MAV = -88 mV; V max = 790 V/sec and APD50 and APD90 = 365 and 450 msec, respectively. The earliest consistent effect of QX-314 in the same concentrations was to decrease action potential duration. This was followed by a decrease in V ma x and action potential amplitude. There was a decrease in MDP of all fibers at 10" 4 .M. The time course of the effects of QX-314 on V max was 2-4 times slower than for lidocaine; moreover, once there changes had occurred they could not be reversed to any significant extent by superfusing the preparation with control solution for 60 minutes or more. The extent to which QX-314 typically modified transmembrane potentials also is illustrated in Figure 2 . After 1 hour of exposure to QX-314 (HT 5 M), the action potential amplitude decreased from 136 to 124 mV, MAV decreased from -94 to -90 mV, and V max from 520 to 310 V/sec. Both APD50 and APD90 had shortened markedly. After exposure to 10 4 M QX-314, action potential amplitude was 102 mV and MAV still was -90 mV, but V max was only 110 V/sec. There was a further decrease in APD50 to 150 msec, whereas APD90 remained at 320 msec. At this time the action potential upstroke was so markedly attenuated that phase 0 seemed to merge with the initial phase of the plateau and there was no early phase of rapid repolarization (phase 1). As shown in Figure 2 , superfusion with control Tyrode's solution for 60 minutes caused little reversal of the effects of QX-314. Action potential amplitude remained at 103 mV and V max at 170 V/sec. APD50 and APD90 increased to 170 and 340 msec, respectively. Like lidocaine, QX-314 depressed the plateau, moving it to more negative voltages. In some fibers the change in transmembrane voltage at the onset of phase 2 was quite dramatic: the start of phase 2 shifted from +12 mV to zero mV in 10~5 M QX-314 and to -10 mV in 10" 4 M QX-314.
In general, we used the transmembrane potential at 50% of repolarization (APD50) as a measure of drug effect on the plateau and the duration at 90% of repolarization (APD90) to approximate total action potential duration. With a concentration of QX-314 of 10~5 M the transition from phase 2 to phase 3 occurred earlier than in the control solution. During phase 3, however, there was a slowing of repolarization. This slowing was most prominent during the terminal portion of phase 3. With higher concentrations of QX-314, the slowing of phase 3 VOL. 43, No. 4, OCTOBER 1978 was more pronounced and, in combination with accelerated repolarization during phase 2, generated an action potential in the shape of a triangle with little or no clear transition between phases 2 and 3 ( Fig. 2) . Also, the terminal portion of phase 3 repolarization was slowed sufficiently that APD90 shortened only slightly, if at all, and total action potential duration frequently was prolonged. This slowing of the very terminal portion of repolarization has also been reported for high (10~4 to 2 X lCT 4 M) concentrations of lidocaine but we did not observe it consistently.
We also studied two other lidocaine derivatives by superfusion: QX-572, a permanently charged quaternary compound with larger iV-terminal substituent than QX-314, and compound 6603, a tertiary lidocaine analogue that is almost totally (>99%) ionized at body pH. The effects of these two agents on the transmembrane potential also are illustrated in Figure 2 and summarized in Table 1 . Superfusion with QX-572 produced changes in the action potential quite similar to those caused by QX-314 and also quite refractory to reversal by superfusion with control solution. QX-572 caused a concentration-dependent decrease in V max , action potential amplitude, and action potential duration. There was some loss of resting membrane potential (measured as membrane activation voltage in Table  1 ) although this was not significant at the lower concentration. QX-572, at a concentration of 10" 5 M, appeared to produce less action potential shortening and upstroke depression than did QX-314, but at 10~4 M the effects of the two agents were comparable. Although the transmembrane potentials in Figure 2 , illustrating effects of QX-572 and QX-314, suggest that at 10" 4 M QX-314 is the more potent depressant of phase 0, Table 1 shows that, at this concentration, their effects are similar. QX-314 reduced V max to 31.8% of control and QX-572 to 33.8% of control.
Compound 6603 produced changes in the transmembrane potential like those brought about by the permanently charged agents. (Fig. 2 and Table  1 ). The amplitude of phase 0 and V ma x were attenuated and action potential duration shortened. At a concentration of 10~4 M there was some loss of resting potential. The overall effect on the action potential was similar in magnitude to that of QX-314 and QX-572 at the same concentration. Unlike the results obtained when fibers were exposed to the quaternary derivatives, however, superfusion with control solution largely or completely reversed the effects of 6603. For example, in the experiment with 6603 illustrated in Figure 2 , the control action potential amplitude is 130 mV but after washout returns to 131 mV. The control value for Vmax is 730 V/sec; this falls to 250 V/sec during exposure to 6603 and after washout is restored to 500 V/sec. For the fibers analyzed in Table 1 ,10~4 M 6603 depressed V ma]t to 32.8% of the control value and washout restored it to 86.5% of control. In addition, after washout with control Tyrode's solution, action potential duration frequently was longer and membrane activation voltage more negative than the control values. For example, in Figure 2 the control action potential duration was 360 msec; this shortened to 300 msec after superfusion with 10~4 M 6603 for 30 minutes (not shown). Then, while the APD50 continued to decrease, APD90 lengthened to 340 msec as the terminal part of phase 3 repolarization prolonged. Washout of 6603 with control solution increased APD90 to 410 msec.
Effects on Phase 4 Depolarization
In a number of experiments, the impaled cells exhibited spontaneous diastolic depolarizations that permitted observation of the effects of lidocaine and QX-314 on the slope of phase 4. Lidocaine, at a concentration of 10~5 M, promptly and reversibly decreased the slope of phase 4. In contrast, QX-314, at equimolar or twice the concentration, did not decrease the slope of phase 4. This was so even when 1 hour of superfusion with QX-314 had resulted in a marked decrease in V ma x and action potential amplitude and shortening of action potential duration. Because there was significant variation in the control rate of diastolic depolarization among different preparations of Purkinje fibers, an attempt to make a quantitative comparison of the effects of lidocaine and QX-314 on the slope of phase 4 would not have yielded meaningful results if we had pooled data from different fiber bundles. Instead, in several experiments we chose to study multiple cells in one Purkinje fiber bundle before and after exposure to lidocaine by making repeated impalements throughout the duration of the experiment; this technique permitted measurement of the slope of phase 4 at a number of sites with less inherent variability between values for each site under each experimental condition. The results of one such experiment are presented in Table 2 . For this preparation, fibers in 10 different areas were impaled and their transmembrane potentials recorded. This procedure was then repeated after superfusion with each of the following solutions: 10~5 M lidocaine, control solution, 10~5 M QX-314, 2 X 10" 5 M QX-314, and then 10" 5 M lidocaine. Superfusion with 10~5 M lidocaine produced significant shortening of the action potential duration and a clear decrease in the slope of phase 4 from 3.87 to 2.13 mV/sec but no significant changes in action potential upstroke or Vmax-On superfusion with the control solution, the slope of phase 4 depolarization returned to control value and action potential duration was nearly as long as before exposure to lidocaine. After superfusion with 10~5 M QX-314, the slope of phase 4 increased slightly, from 3.85 to 4.30 mV/sec. Action potential duration and V max were decreased, as expected, and maximum diastolic potential decreased by 3 mV. These latter changes became more prominent after the fiber was exposed to 2 X 10" 5 M QX-314: V max fell to 287 V/sec and action potential duration to 326 msec. The slope of phase 4, however, remained essentially unchanged at 4.34 mV/sec. Finally, when the fiber was superfused a second time with 10~5 M lidocaine, the slope of phase 4 again decreased, this time to 2.98 m V/sec. Lidocaine also produced a small further decrease in action potential duration and there was a small increase in V m ax and maximum diastolic potential. In the experiment on this preparation, and in several others, QX-314 did not decrease the slope of phase 4, whereas lidocaine did. Instead, QX-314 appeared to produce, if any change, a small increase in the rate of diastolic depolarization. Similar results were obtained from studies on a large number of individual fibers in different preparations when impalement was maintained during sequential exposure to lidocaine, control solution, and QX-314. As was the case for QX-314, QX-572 did not decrease the slope of phase 4 depolarization at concentrations of 10~5 and 10~4 M; during exposure to this agent, the slope of phase 4 was unchanged or minimally increased. Like the quaternary derivatives, compound 6603 did not decrease the slope of phase 4 depolarization in the concentrations studied.
Drug Application by Iontophoresis
For these experiments, iontophoresis was used to inject drugs intracellularly. Under the dissecting microscope, a Purkinje fiber bundle was impaled with two electrodes separated by a known distance. One electrode contained the experimental drug and was used alternately to inject drug and measure the transmembrane potential, while the other, a standard KC1 microelectrode, recorded changes in the transmembrane potential at a known distance (0.2 to 3 mm) from the injection site. Pulses of known amplitude and duration were delivered by a constant current generator to the impaled cell via the drug-filled electrode. Iontophoresis occurred as positively charged drug molecules carried part of the current between the electrode and the cell interior. Current pulses of similar amplitude and duration delivered via the KC1 electrode did not alter the transmembrane potential.
When the microelectrode was filled with 0.5 M lidocaine, a current of 1 X 10" 7 amps for 30 seconds caused a transient decrease in the AP amplitude and V max and, sometimes, in maximum diastolic potential. However, there was no change in action potential duration. Records from a typical experiment in which lidocaine was injected are shown in Figure 3 . In Figure 3 (both A and B) , the arrangement of the tracings shows the transmembrane potentials recorded through the lidocaine electrode on the left. The top pair of records are the controls, the middle pair show the maximum effect of iontophoretic injection, and the bottom pair show the maximum extent of recovery recorded. In Figure  3A , the control record through the lidocaine electrode shows an essentially normal transmembrane potential, but the value of V max is abnormally low. This probably resulted from some leakage of lidocaine from the electrode. The record through the KC1 electrode, located 1.5 mm from the injection site, is normal. The middle panels show that after a current pulse of 1 X 10~7 A for 30 seconds, the only change at the injection site is a decrease in Vmax from 375 to 225 V/sec. There are no changes at the remote site. The bottom traces, recorded 60 seconds after injection, show that the control value of V m ax has been restored. Figure 3B shows results from another injection of lidocaine. Here records were obtained from two different cells and the KC1 electrode was located 0.25 mm from the injection site. In the top panels the record of transmembrane potential recorded through the lidocaine electrode shows a smaller resting potential and overshoot than that recorded through the KC1 electrode. Also, Vmax recorded through the lidocaine electrode is only about 300 V/sec. After a current of 2 x 10~7 A for 30 seconds (middle panels) there is a significant decrease in resting potential, action potential amplitude, and Vmax at the injection site and smaller changes in these variables at the.remote site. At the remote site, the decrease in V ma x is greater than can be accounted for by the decrease in resting potential. Figure 3A , except that the interelectrode distance is now 0.25 mm. Row 1: controls; row 2: immediately after 2 x 10'"' A was passed for 30 seconds; row 3: 2 minutes after drug injection. See text for discussion.
voltage, the duration of the plateau, or the action potential duration. The bottom panels show that 2 minutes after injection, the control values have been restored. In this and other experiments we found that transmembrane potentials recorded at distances of 1 mm or more from the injection site showed no change during injection of lidocaine with currents of up to 1 X 10~6 A and with a total duration of 60 seconds. That intracellular injection of lidocaine produces localized and highly reversible effects is not surprising. Even though some 80% of the molecules are charged at intracellular pH, the concentration gradient heavily favors efflux from the fiber for any permeable form. As the uncharged molecules penetrate the membrane and are removed from within the fiber, charged molecules lose protons in order to maintain the charged-uncharged ratio. In this manner, the intracellular concentration of lidocaine rapidly decreases. Even compounds such as 6603, which is >99% ionized at body pH, may be rapidly removed from the cell (see Fig. 2 ). The quaternary derivatives, on the other hand, are removed at a very slow rate. This is shown by the effects of iontophoretic injection of QX-314. In contrast to lidocaine, intracellular injection of QX-314 produced changes in the action potential upstroke that were progressive rather than reversible and extended over a much larger segment of the fiber. Figure 4 illustrates results of such an experiment. The panels on the left show transmembrane potentials recorded during a maintained impalement with the electrode containing QX-314. Each panel on the right was recorded at the same time as the corresponding panel on the left but through a KCl electrode during continuous impalement at a site 0.2 mm from the QX-314 electrode. The top two traces in Figure 4A are controls recorded just after the tip of the QX-314 electrode was placed inside the fiber. The second row of action potentials also are controls recorded 2 minutes later. In this case, in the absence of an injection current, the passive leak from the quaternary electrode was sufficient to decrease V max at the injection site from 340 to 200 V/sec. After 1 x 10~7 A for 30 seconds had been delivered via the QX-314 electrode (row 3), at the injection site the changes are prompt and marked: V max is depressed to 160 V/sec and action potential amplitude falls from 136 to 127 mV. At the reference site, V m ax has decreased from 560 to 360 V/sec and action potential amplitude from 140 to 129 mV, and by 5 minutes after injection, these values decreased to 100 V/sec and 123 mV, (Fig. 4B, top row) . During this period there was no change in the resting potential at the reference site. Over the next hour, without further drug injection, the changes at both sites were progressive. As shown in the bottom row of Fig. 4B , at the injection site V ma x fell to 33 V/sec and action potential amplitude to 112 mV. At the reference site, the values for these parameters were Figure 4A , arranged in the same manner. The calibration step for V max now corresponds to 100 V/sec. Row 1:5 minutes after injection; row 2:15 minutes after; row 3: 45 minutes after. See text for discussion. 45 V/sec and 116 mV. At neither site was there a change in action potential duration although the plateau was shifted to slightly more negative potentials. In all experiments the intracellular injection of the quaternary derivative caused dramatic and prompt changes in the transmembrane potentials recorded at and near the site of injection, as shown in Figure 4 . In cells at greater distances from the site of injection these changes occurred more slowly and over a longer period of time as the lidocaine derivative diffused along the fiber from the site of initial application. However, despite the marked changes in V max and AP amplitude that were caused by intracellular injection of QX-314, and regardless of the area over which these changes were noted, in no experiment was there a significant alteration in action potential duration (APD90).
To study further the spatial distribution of effects, in some experiments, we recorded transmembrane potentials from several sites in a fiber bundle, injected QX-314 into one or more cells, and then periodically recorded from each of the initial sites. Data collected in this manner permitted preparation of a map of the fiber that illustrated the effects of quaternary injection as a function of geometry. Figure 5 illustrates the results of one such experiment. A representation of the fiber bundle, along the bottom, shows the injection site and the points 0.5 mm 10T 1 A, 50 seconds) at which the transmembrane potentials were recorded before and after injection. Site 1 was located approximately 0.12 mm from the injection site. The record in 1A was made just before injection of QX-314 (1 X 10" 7 A, 50 seconds); the other records all were obtained after injection. At site 1, QX-314 caused a marked decrease in resting potential, action potential amplitude, and Vma X , but no change in action potential duration (IB). There were changes of similar magnitude at site 2, on the opposite side of the injection site and 0.35 mm from it. Sites 3 and 4, located 1 and 1.5 mm from the injection site on either side of it and in the same fiber bundle, both show the typical effects of quaternary action: action potential amplitude is decreased, overshoot is abolished, and V ma x severely depressed. At site 5, only 0.4 mm from site 4 but in a different fiber bundle, the action potential is normal at this time. Thus, injection at a single site depressed a long and relatively narrow segment of the fiber. This suggests that QX-314 molecules preferentially diffuse along or within fiber bundles rather than radially across fibers and sheaths. In records from the same site obtained before (1A) and after (IB) injection of QX-314, the action potential duration is unchanged. Similarly, at a site presumably unaffected by the drug (site 5) and at another site clearly depressed by the quaternary derivative (site 4), action potential durations are equal.
FIGURE 5 The effects of intracellular iontophoretic injection of QX-314. Along the bottom is a schematic representation of the fiber, specifying the sites at which the six records, shown above, were made. In each panel the upper trace represents the transmembrane potential, the lower trace its dv/dt, preceded by a calibration. The calibration is 200 V/sec in panels 1A and 5, and 100 V/sec in all others. A line corresponding to zero transmembrane voltage also is shown. Panel 1A was recorded prior to the injection (1 x
Because iontophoretic injection of QX-314 at one site affects a long and presumably narrow area of the preparation, the cells with altered transmembrane potentials are in close proximity to a larger mass of cells not exposed to the drug. This surrounding normal tissue might electrotonically influence the transmembrane potential of cells containing QX-314 and conceal or modify certain drug effects. In an attempt to obtain preparations with a more uniform distribution of the drug, we performed additional studies of the sort illustrated in Figure 6 . The preparation is represented schematically in the following way. Sites X, Y, and Z are sites in three different fiber bundles selected for drug injection. The other sites (A through L) were located in rows perpendicular to the row of injection sites (A, B, C) and at known distances along a fiber bundle (A, D, G, J). During the control period, records were obtained from all designated sites. Representative control records at different distances from an injection site, but in the same fiber sites and records obtained immediately and after 60 minutes (D-4, E-4, F-4). The upper part of Figure  6 illustrates the changes in transmembrane potential that occurred at sites B, E, and H following the first injection of QX-314. The records B-0, E-0, and H-0 were made during the control period and, at each site, the action potential has an amplitude of at least 120 mV and V max is 600-800 V/sec. The records in the second row (B-l, E-l, H-l) were obtained immediately after the initial injection. Cells at all three sites are affected, but by far the greatest changes occur at the site closest to the injection (B-l). Here, action potential amplitude falls from 123 to 94 mV, V max from 600 to 50 V/sec, and APD50 from 250 to 185 msec. APD90 remains unchanged at 410 msec. Measurements at sites A and C at this time showed nearly identical changes. At site E, the changes are similar but less marked. Action potential amplitude has decreased from 128 to 108 mV, Vmax from 770 to 360 V/sec, and ADP50 from 290 to 195 msec. APD90 is 410 msec in both panels E-0 and E-l. At the site H, the most distal of the three, the changes observed are the least marked.
QX-314 was then injected at sites X, Y, and Z, (1 x 10' 1 A for 30 seconds at each site). Records were made immediately after injection; (B-l, E-l, and H-l are representative tracings) and one-half hour later (B-2, E-2 and H-2). At this time, a second injection (1 x 10' 1 A, 30 seconds) was made at sites X, Y, and Z and another two sets of recordings were made, one immediately after injection (A-3, B-3, etc.) and another 1 hour later (D-4, E-4, F-4, etc). In each panel in this figure, the transmembrane potential is the tracing on top; dv/dt is below. The calibration for dv/dt is 200 V/sec in B-0, E-0, HO, E-l, H-l, and H-2, and 100 V/sec in the other panels. [K + ]
The records in the bottom row (B-2, E-2, H-2), obtained 30 minutes after injection, showed that in this period sufficient amounts of drug have reached the distal sites to produce significant attenuation of the upstroke. At site E the action potential amplitude has decreased from 108 to 95 mV and V max from 360 to 75 V/sec without significant change in resting potential. The cell at site H also shows loss of action potential amplitude (120 to 104 mV) and upstroke velocity (570 to 400 V/sec) without loss of resting potential. The diffusion of QX-314 during the half hour separating the two sets of measurements was such that the action potentials in E-l and H-2 show roughly comparable levels of upstroke attenuation. The records in the bottom of the figure (D-0, D-4; E-0, E-4; F-0, F-4) show that, at any distance from the sites of injection, and at any particular time, the magnitude of the effect is similar along the transverse axis.
This method of injection produced a strip of Purkinje fiber bundles in which there were significant drug-induced changes over its entire width and, longitudinally, for a distance of at least 4 mm on one side of the injection sites. Again, the clearest initial effect of intracellular application of QX-314 was attenuation of phase 0; V max and action potential amplitude clearly were depressed and at any time the magnitude of this effect was greater for fibers closer to the injection site (compare B-l, E-l, H-l). At most sites, prominent depression of phase 0 was noted before there was much change in resting or maximum diastolic potential (see B-0 and B-l; E-0 and E-l). Also, as expected, the rate at which the drug induced changes appeared to depend on the distance between the site of injection and the recording site. In spite of this, it was possible to achieve fairly intense effects over a considerable length of the fiber.
In this experiment there was no significant alteration in total action potential duration as measured by APD90, although the plateau consistently was shifted to more negative potentials. This was true both for cells showing severe attenuation of action potential amplitude and V max as well as for those in which little or no alteration of phase 0 was evident and the only sign of drug action was the shift in phase 2. Additional data supporting this conclusion are provided by Figure 7 which summarizes the changes in action potential amplitude, plateau phase, and action potential duration at sites D through L. Here a vertical row of bar graphs (D, E, F) corresponds to the sites with the same designations in Figure 6 . For each site we have plotted four variables as a function of time: the bar graphs in the upper left show action potential duration at 0 mV, those in the upper right show action potential duration at -40 mV, those in the lower left show action potential duration at 90% repolarization, and those in the lower right show action potential amplitude. We used the duration of the action potential at 0 and -40 mV to demonstrate the shift of the plateau to more negative potentials. Each parameter was measured five times: the control value is shown on the left (0) and followed by values measured immediately after the first injection of QX-314 (1), 30 minutes later (2), immediately after the second injection (3), and again 30 minutes later (4). Measurements were not made at sites G, I, J, and L immediately after the second injection.
The figure shows that, at each of the recording sites, QX-314 depressed the plateau, and this depression became more marked with time. Also, the change in the plateau was the earliest effect noted. This is shown well by sites J, K, and L. At site K, during the first three sampling periods, action potential duration at 0 mV decreased from 140 to 130 and then 100 msec and at -40 mV from 340 to 335 and then to 305 msec while action potential amplitude remained essentially unchanged (132, 128, and 132 mV). V max , not shown, did not decrease during this period. Similar changes were found at sites J and L. As shown in Figure 6 , action potential amplitude decreased most rapidly at sites near the injection and there was little differences in the rate or magnitude of change between sites in any row perpendicular to the injection sites. In spite of the changes in action potential amplitude and duration and in the voltage level of the plateau, Figure 7 shows that action potential duration, at 90% repolarization, did not change after repeated injection of QX-314.
Discussion
One purpose of these studies was to determine the site of action and active form of lidocaine in cardiac tissues. Previous electrophysiological investigations, carried out in squid giant axon by Narahashi et al. 1 ' 2 showed that tertiary and quaternary lidocaine derivatives block generation of the action potential by acting from inside the membrane and in the charged state. In addition, in nerve, local anesthetics like procaine and lidocaine attenuate VOL. 43, No. 4, OCTOBER 1978
The effects of intracellular injection of QX-314. This bar graph summarizes the results of the experiment shown in Figure 6 . For sites D through L on the fiber the changes in four variables are shown: action potential duration at 0 mV (upper left); action potential duration at -40 mV (upper right); action potential duration at 90% repolarization (lower left); and action potential amplitude (lower right). At each site, and for each of these parameters, five measurements were made (one before and four after drug injection), and are plotted from left to right. No values for G3,13, J3, and L3 were obtained. See text for discussion. and slow the increase in K + conductance caused by depolarization and depress the steady state (potasium) conductance. 14 In the case of isolated preparations of cardiac Purkinje fibers, the effect of lidocaine on the upstroke of the action potential appears to be similar to that shown for nerve: 3 " 6 the maximum rate of rise and amplitude of phase 0 are decreased in a dose-dependent manner, and effects are easily reversed by exposure to drug-free solution. In addition, however, lidocaine exerts additional effects on cardiac fibers that are not explained by data obtained from studies on nerve. The time constant for reactivation of the fast inward channel is markedly increased, 8 ' 9 the voltagetime course of repolarization is accelerated as a result of effects on both phases 2 and 3, and the slope of diastolic depolarization is diminished. Unlike nerve, Purkinje fibers appear to show an increase in steady state potassium conductance. 7 In the studies reported here we exposed cardiac Purkinje fibers to lidocaine and several selected derivatives both by superfusion and intracellular injection. The two methods were used (1) to determine what effects resulted from exposure of the outer and inner surfaces of the sarcolemma to the local anesthetics, (2) to evaluate the ease with which the agents penetrated the membrane, and (3) to determine which actions might result from effects of the charged and uncharged forms. We found that several of the effects of lidocaine are exerted at different sites and also that certain effects are caused by the charged form of the molecule but others are not.
Each of the agents, when added to the superfusate, exerted qualitatively similar effects on the maximum rate of rise and amplitude of phase 0 and on the voltage-time course of phases 2 and 3. It seems reasonable to assume, therefore, that lidocaine, the two quaternary derivatives and compound 6603 were similar enough in pharmacological actions to be suitable for the studies conducted.
In considering the results of our studies and the possible implications of our results, it is helpful to deal first with the effects of lidocaine and its quaternary derivative QX-314 on phase 0 of the transmembrane action potential. One of the typical effects of a sufficiently high concentration of lidocaine on the transmembrane potentials of cardiac Purkinje fibers is to decrease the maximum rate of depolarization during phase 0 and to decrease the amplitude of phase 1 of the transmembrane action potential. It is not surprising that, when lidocaine was injected intracellularly, the locally recorded transmembrane action potential showed a decrease in Vmax and a decrease in amplitude. The more interesting findings were those made when QX-314 was injected intracellularly in the same manner. This quaternary lidocaine derivative decreased the amplitude of phase 0 and V max in the same manner as did lidocaine. After a single injection of QX-314, the attenuation of the transmembrane action potential upstroke persisted at the injection site and, with time, became progressively more intense at sites remote from the point of injection. The spatial distribution of these effects was more marked along the long axis of the fiber bundles than along the transverse diameter of the preparation. Finally, because the reversal of these effects of the quaternary derivative was so slow, it is clear that diffusion of drug from within the fiber to the outer surface of the sarcolemma did not result in any appreciable extracellular concentration. Each of these findings suggests that, after injection by iontophoresis, the molecules of QX-314 and lidocaine modify the timeand voltage-dependent fast inward current by gaining access to some site from the inner surface of the sarcolemma and also that it is the charged form of the anesthetic molecule which interacts with this site. These findings were to be anticipated and, as stated earlier, are similar to results obtained for nerve.
In terms of the conclusion that the charged form of the molecule acts from the inner surface of the sarcolemma to depress the action potential upstroke, it is possible to evaluate some other aspects of our experiments. Two questions about membrane permeability deserve some consideration. It often is implied that cardiac fiber membranes are quite impermeable to the charged form of antiarrhythmic agents and other drugs. From the effects we observed during superfusion with quaternary derivatives of lidocaine and with compound 6603, which is almost totally ionized at a physiological value of pH, it seems that the membrane of the Purkinje fibers is reasonably permeable to the charged form of these molecules.
Clearly it is possible that each molecule caused changes in the action potential upstroke by interacting with a unique site. Thus the effects on V ma x of the quaternary derivatives, when applied by superfusion, might have resulted from their interaction with a site on the outer surface of the membrane, and their effect on V max when applied by intracellular iontophoresis might have resulted from an interaction with a different site on the inner surface. Most available data suggest that this is quite unlikely. 1 ' 2 ' 15 Therefore we will interpret our findings in terms of the possibility that the charged form of the molecules can penetrate the sarcolemma and interact with the same site as lidocaine to decrease Vmax.
When each of the quaternary lidocaine derivatives was added to the superfusate, each exerted typical effects on the amplitude of phase 0 and on V max . Although these effects developed more slowly than they did for lidocaine, the difference was not exceedingly great. Since we have concluded that effects of lidocaine and QX-314 on phase 0 are due to molecules acting from the inner surface of the sarcolemma, we can reason that the Purkinje fiber sarcolemma is permeable to the permanently charged lidocaine derivatives. If this is so, there is no reason to assume that only the uncharged form of compound 6603 was able to penetrate the membrane from the extracellular surface. The persistence of the effects of the two quaternary derivatives, in contrast to the reasonably rapid reversal of the effects of compound 6603, may reflect only the fact that a small fraction of the latter is uncharged and thus subject to less hindrance in crossing the sarcolemma. However, it also may result from firmer binding of the quaternary derivatives. Our results do not permit a conclusion on this point.
Because of the electrotonic coupling between adjacent areas of membrane, we could not accurately time the onset of drug effect at a given site and thus could not measure diffusion of the quaternary molecules from the site of injection to adjacent fibers. Nevertheless, the results shown in Figures 4, 5, and 6, which demonstrate the diffusion of QX-314 along fiber bundles over distances of a number of mm, show that some part of the intercalated disc membrane, most likely the gap or tight junctions, is reasonably permeable to the permanently charged local anesthetic molecules. If this were not so, it would be difficult to explain the observation that after a single intracellular injection of QX-314 there was a progressive increase in the effect on V max of cells located at increasing distances from the site of injection. Indeed, the likelihood that QX-314 can escape from the cells through the sarcolemma seems to be very much less than the likelihood that the molecules will migrate into adjacent cells. Evidence in favor of this is summarized below.
Since we have concluded that the charged lidocaine derivatives do penetrate the sarcolemma and gain access to the inner surface of this membrane, it is possible to evaluate the results of our studies on phase 4 depolarization. When lidocaine was added to the superfusate in reasonably low concentration (1 X 10~5 M) it caused the expected decrease in the slope of phase 4. When the same preparations were exposed to either QX-314, QX-572 or compound 6603 (data not shown) in concentrations of 10~5 or 10~4 M, the slope of phase 4 depolarization did not decrease. Since we have concluded that each of these three lidocaine derivatives does penetrate the sarcolemma, their lack of effect on phase 4 depolarization cannot be attributed to an inability to reach a site of action on the inner surface of the membrane. It seems more reasonable, therefore, that the site at which lidocaine acts to modify phase 4 depolarization is one which interacts with the neutral rather than the charged form of the local anesthetic. Since lidocaine and QX-314 differ only in that QX-314 has an additional ethyl group on the nitrogen atom and consequently a permanent charge, binding at the site that regulates the pacemaker current (in,2) may be restricted to compounds in which the nitrogen has only three substituents VOL. 43, No. 4, OCTOBER 1978 (two free electrons) and no net charge. It is conceivable, however, that the three-dimensional geometry of this site is such that compounds with large TV-terminal substituents, irrespective of total charge, cannot be accommodated. Unfortunately our studies do not permit us to localize the site of action of these agents on phase 4 depolarization to either the inner or the outer surface of the membrane.
The effects of lidocaine and its derivatives on action potential duration and on the voltage level of the plateau are somewhat more difficult to interpret. As expected, when lidocaine was added by supervision, the voltage level of phase 2 became more negative and action potential duration, measured as APD50 and APD90, was clearly decreased (Table 1, Fig. 2 ). The charged derivatives had qualitatively similar effects when added to the superfusate, although depression of plateau voltages perhaps was more marked. At 10~4 M, QX-314 and compound 6603 prolonged the terminal portion of phase 3 so that total action potential duration often approximated or exceeded the control value; this also may occur with high concentrations of lidocaine. When QX-314 was injected intracellularly, once again the plateau was shifted to more negative voltages. These findings indicate that depression of the plateau most likely is mediated by the charged form of the molecule. Also, since it is unlikely that QX-314, when administered by intracellular iontophoresis, diffused out of the cell with sufficient rapidity to attain an appreciable extracellular concentration, it is probable that when lidocaine and its derivatives modify the plateau voltages they do so by acting from the inner surface of the sarcolemma.
The somewhat puzzling finding was that when QX-314 was injected intracellularly there was no significant decrease in action potential duration regardless of the extent to which the plateau had been depressed. When QX-314 was injected at a single site ( Fig. 5 ), the action potential duration (APD90 and total APD) at that site and at nearby sites did not change even though there were marked alterations in the amplitude of phase 0 and V max . This might be explained by assuming that during phase 0, because of the significant decrease in membrane resistance, the local effects of drug on the inward sodium current were apparent, but during phases 2 and 3 when membrane resistance is higher, the local effects on APD were masked by electrotonic interaction with distal sites not yet acted on by drug. That this is not the case is shown by the results of experiments in which larger areas of the fiber bundle were affected by the injected drug. Even when injected QX-314 had diffused along the axis of the preparation and attained a sufficient concentration to depress V max , AP amplitude, and phase 2 voltage over a considerable extent (Figs. 6 and 7) of the preparation, action potential duration was not significantly decreased. It seems likely, therefore, that lidocaine and its derivatives decrease action potential duration by acting at a site approached from the outside, but not the inside, of the membrane.
We realize that the interpretations we have made of the results of our studies are crucially dependent on certain assumptions. The first of these is that both the uncharged and charged molecules can penetrate the membrane although penetration by the latter is much slower than by the former. The second is that when the charged molecule, QX-314, is injected intracellularly, the likelihood that it will diffuse from cell to cell through intercellular connections is much greater than the likelihood that it will cross the sarcolemma from inside to outside and act on the outer surface of the membrane. The assumption that QX-314 might pass from cell to cell through the intercellular connections is made reasonable by the demonstration that potassium 16 ' 17 cyclic adenosine 3',5'-monophosphate, 18> 19 tetraethylammonium ions, 20 and dyes of graded molecular sizes 2 ' 122 diffuse through the intercellular junctions of cardiac fibers. That in our experiments QX-314 also diffused from the intracellular space of one fiber to that of immediately adjacent fibers through the tight or gap junctions is not proven by our data. Nevertheless it seems most likely that it did so. All available data indicate that diminution of the fast inward current (g Na ) by local anesthetics results from interaction of the anesthetic with a site on the inner surface of the membrane 1 ' 2| 15 There is no reason, a priori, to assume that the mechanism for the quaternary local anesthetics is different. One thus can conclude that in these experiments a decrease in the maximum rate of change of the action potential upstroke and a decrease in its amplitude, if not due to a decrease in activation voltage, signal the presence of the local anesthetic molecules at the inner surface of the membrane. It still would be possible, however, that the local anesthetic moved from cell to cell by exiting from one and entering the next from the extracellular space. We have concluded that this is not the case because, when any of the agents tested was applied by superfusion, there was a decrease in action potential duration. In contrast, when QX-314 was applied intracellularly by iontophoresis, an effect on V max of fibers progressively farther from the site of injection increased with time but there was no change in action potential duration. This was true when a sufficiently large area of the preparation was affected to preclude electrotonic clamping of membrane potential during repolarization by fibers not acted on by the drug.
It is tempting to assign each of the effects of lidocaine and its derivatives to an interaction with a specific trans-sarcolemmal ionic conductance. Because of studies conducted on nerve, there is little difficulty in attributing the decrease in the amplitude of phase 0 and V max to interaction of the charged form with the inner end of the fast inward channel, gNa-Because we found that lidocaine, but not the charged derivatives, decreased the slope of phase 4 depolarization, we have assumed that this effect results primarily from interaction of the neutral molecules of lidocaine with gK,2-Finally, one could explain the observed effects with respect to action potential duration and the plateau voltages by assuming that the shift in phase 2 to more negative voltages occurs when the charged molecules act from within the membrane on the secondary inward current, i S i, and action potential duration decreases when the charged molecules interact from the outer surface of the sarcolemma with the delayed outward current, i x ,i. In summary, one effect of local anesthetics on cardiac Purkinje fibers is the same as on nerve; that is the concentration-dependent effect on the fast inward current that is due to interaction between the charged molecule and the inner surface of the membrane. The other effects of lidocaine and its derivatives on Purkinje fibers do not have a clear counterpart in nerve. This probably is due to the fact that the ionic conductances which control action potential duration, plateau voltage, and phase 4 depolarization either are not present in nerve or make only insignificant contributions to the voltage-time course of the transmembrane action potential. The mechanism by which high concentrations of local anesthetics modify potassium conductance of nerve also may be the mechanisms responsible for both the decrease in maximum diastolic and resting potential of Purkinje fibers and the slowing of the terminal part of phase 3; this we have not tried to evaluate. Studies with voltageclamp techniques might provide the data needed to evaluate these assumptions.
